Your browser doesn't support javascript.
loading
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models.
Meehan, Terrence F; Conte, Nathalie; Goldstein, Theodore; Inghirami, Giorgio; Murakami, Mark A; Brabetz, Sebastian; Gu, Zhiping; Wiser, Jeffrey A; Dunn, Patrick; Begley, Dale A; Krupke, Debra M; Bertotti, Andrea; Bruna, Alejandra; Brush, Matthew H; Byrne, Annette T; Caldas, Carlos; Christie, Amanda L; Clark, Dominic A; Dowst, Heidi; Dry, Jonathan R; Doroshow, James H; Duchamp, Olivier; Evrard, Yvonne A; Ferretti, Stephane; Frese, Kristopher K; Goodwin, Neal C; Greenawalt, Danielle; Haendel, Melissa A; Hermans, Els; Houghton, Peter J; Jonkers, Jos; Kemper, Kristel; Khor, Tin O; Lewis, Michael T; Lloyd, K C Kent; Mason, Jeremy; Medico, Enzo; Neuhauser, Steven B; Olson, James M; Peeper, Daniel S; Rueda, Oscar M; Seong, Je Kyung; Trusolino, Livio; Vinolo, Emilie; Wechsler-Reya, Robert J; Weinstock, David M; Welm, Alana; Weroha, S John; Amant, Frédéric; Pfister, Stefan M.
Afiliação
  • Meehan TF; European Molecular Biology Laboratory-European Bioinformatics Institute, Hinxton, United Kingdom. tmeehan@ebi.ac.uk.
  • Conte N; European Molecular Biology Laboratory-European Bioinformatics Institute, Hinxton, United Kingdom.
  • Goldstein T; Institute for Computational Health Sciences, University of California, San Francisco, California.
  • Inghirami G; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.
  • Murakami MA; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Brabetz S; Hopp-Children's Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany.
  • Gu Z; Division of Pediatric Neuro-oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Wiser JA; Northrop Grumman Information Systems Health IT, Rockville, Maryland.
  • Dunn P; Northrop Grumman Information Systems Health IT, Rockville, Maryland.
  • Begley DA; Northrop Grumman Information Systems Health IT, Rockville, Maryland.
  • Krupke DM; The Jackson Laboratory, Bar Harbor, Maine.
  • Bertotti A; The Jackson Laboratory, Bar Harbor, Maine.
  • Bruna A; Candiolo Cancer Institute, FPO-IRCC, Department of Oncology, University of Torino, Torino, Italy.
  • Brush MH; Cancer Research UK Cambridge Institute, Cambridge Cancer Centre, University of Cambridge, Cambridge, United Kingdom.
  • Byrne AT; Department of Medical Informatics and Clinical Epidemiology and OHSU Library, Oregon Health and Science University, Portland, Oregon.
  • Caldas C; Royal College of Surgeons in Ireland, Ireland.
  • Christie AL; Cancer Research UK Cambridge Institute, Cambridge Cancer Centre, University of Cambridge, Cambridge, United Kingdom.
  • Clark DA; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Dowst H; European Molecular Biology Laboratory-European Bioinformatics Institute, Hinxton, United Kingdom.
  • Dry JR; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Doroshow JH; Oncology Innovative Medicines and Early Development, AstraZeneca R&D Boston, Waltham, Massachusetts.
  • Duchamp O; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Evrard YA; Oncodesign Biotechnology and IMODI Consortium, France.
  • Ferretti S; Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Frese KK; Oncology Disease Area, Novartis Institutes for Biomedical Research, Switzerland.
  • Goodwin NC; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, United Kingdom.
  • Greenawalt D; Champions Oncology, Baltimore, Maryland.
  • Haendel MA; Translational Bioinformatics Bristol-Myers Squibb, Pennington, New Jersey.
  • Hermans E; Department of Medical Informatics and Clinical Epidemiology and OHSU Library, Oregon Health and Science University, Portland, Oregon.
  • Houghton PJ; Katholieke Universiteit Leuven, Leuven, Belgium.
  • Jonkers J; Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
  • Kemper K; The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Khor TO; The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Lewis MT; Institute for Applied Cancer Science, Center for Co-Clinical Trial, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lloyd KCK; The Lester and Sue Smith Breast Center, Departments of Molecular and Cellular Biology and Radiology, Baylor College of Medicine, Houston, Texas.
  • Mason J; Department of Surgery, School of Medicine, and Mouse Biology Program, University of California Davis, Davis, California.
  • Medico E; European Molecular Biology Laboratory-European Bioinformatics Institute, Hinxton, United Kingdom.
  • Neuhauser SB; Candiolo Cancer Institute, FPO-IRCC, Department of Oncology, University of Torino, Torino, Italy.
  • Olson JM; The Jackson Laboratory, Bar Harbor, Maine.
  • Peeper DS; Fred Hutchinson Cancer Research Center, Seattle Children's Hospital, Seattle, Washington.
  • Rueda OM; The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Seong JK; Cancer Research UK Cambridge Institute, Cambridge Cancer Centre, University of Cambridge, Cambridge, United Kingdom.
  • Trusolino L; Research Institute for Veterinary Science and Korea Mouse Phenotyping Center, Seoul, Republic of Korea.
  • Vinolo E; Candiolo Cancer Institute, FPO-IRCC, Department of Oncology, University of Torino, Torino, Italy.
  • Wechsler-Reya RJ; Seeding Science SAS, Paris, France.
  • Weinstock DM; Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, La Jolla, California.
  • Welm A; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Weroha SJ; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
  • Amant F; Department of Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Pfister SM; The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Cancer Res ; 77(21): e62-e66, 2017 11 01.
Article em En | MEDLINE | ID: mdl-29092942
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Antitumorais Modelo de Xenoenxerto / Neoplasias Tipo de estudo: Guideline Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Antitumorais Modelo de Xenoenxerto / Neoplasias Tipo de estudo: Guideline Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article